RING finger protein 10 is a potential drug target for diabetic vascular complications
Autor: | Peng Pu, Ruiyu Wang, Wei Huang, Guiquan Yu, Ming Chen, Siyu Li |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Male Cancer Research Vascular smooth muscle Apoptosis Biochemistry Rats Sprague-Dawley 0302 clinical medicine Cyclin D1 RNA Small Interfering Chemokine CCL2 Macrovascular disease TUNEL assay diabetes NF-kappa B Articles Carotid Arteries Oncology 030220 oncology & carcinogenesis Molecular Medicine medicine.symptom hyperproliferation Signal Transduction medicine.medical_specialty vascular remodeling Myocytes Smooth Muscle Inflammation Nerve Tissue Proteins Diet High-Fat Diabetes Mellitus Experimental 03 medical and health sciences Downregulation and upregulation Internal medicine Diabetes mellitus Genetics medicine Animals Humans Molecular Biology business.industry Tumor Necrosis Factor-alpha Cyclin-Dependent Kinase 4 medicine.disease RING finger protein 10 Rats 030104 developmental biology Endocrinology Gene Expression Regulation inflammation Hyperglycemia Ring finger protein 10 Insulin Resistance business Carrier Proteins Diabetic Angiopathies |
Zdroj: | Molecular Medicine Reports |
ISSN: | 1791-3004 1791-2997 |
Popis: | Vascular remodeling induced by long-term hyperglycaemia is the main pathological process in diabetic vascular complications. Thus, vascular remodeling may be a potential therapeutic target in diabetes mellitus (DM) with macrovascular disease. The present study aimed to investigate the effect of RING finger protein 10 (RNF10) on vascular remodeling under conditions of chronic hyperglycaemia stimulation. We found that overexpression of RNF10 clearly decreased intimal thickness and attenuated vascular remodeling in DM. TUNEL staining showed that apoptosis was clearly inhibited, an effect that may be mediated by decreases in Bcl-2 protein expression. Quantitative analysis demonstrated that overexpression of RNF10 could suppress inflammation by reducing the levels of TNF-α, and MCP-1 mRNA and NF-κB protein. Meanwhile, overexpression of RNF10 prevented vascular smooth muscle cell (VSMC) hyperproliferation through the downregulation of cyclin D1 and CDK4 proteins. Notably, short hairpin RNF10 (shRNF10) greatly aggravated the pathological responses of diabetic vascular remodeling. These outcomes revealed that the differential expression of RNF10 had a completely opposite effect on vascular damage under hyperglycaemia, further displaying the core function of RNF10 in regulating vascular remodeling induced by diabetes. Consequently, RNF10 could be a novel target for the treatment of diabetic vascular complications. |
Databáze: | OpenAIRE |
Externí odkaz: |